Quick Answer
INOVIO PHARMACEUTICALS, INC. reported Stockholders Equity of $24.10 million for fiscal year 2025.
INOVIO PHARMACEUTICALS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $24.10M | -64.8% |
| 2024 | $68.50M | -41.6% |
| 2023 | $117.35M | -47.2% |
| 2022 | $222.36M | -44.4% |
| 2021 | $399.67M | -13.3% |
| 2020 | $461.14M | +13324.4% |
| 2019 | $3.44M | -96.0% |
| 2018 | $86.94M | -38.9% |
| 2017 | $142.39M | +15.5% |
| 2016 | $123.28M | -29.8% |
| 2015 | $175.69M | +58.0% |
| 2014 | $111.23M | +112.0% |
| 2013 | $52.46M | +52.7% |
| 2012 | $34.35M | -27.4% |
| 2011 | $47.31M | +1.7% |
| 2010 | $46.50M | -24.0% |
| 2009 | $61.18M | +220.2% |
| 2008 | $19.11M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$7.72M | -110.5% | -127.1% |
| June 30, 2025 | $28.53M | -70.5% | -44.3% |
| March 31, 2025 | $51.25M | -45.7% | -25.2% |
| December 31, 2024 | $68.50M | -41.6% | -6.8% |
| September 30, 2024 | $73.54M | -46.8% | -24.0% |
| June 30, 2024 | $96.74M | -42.9% | +2.4% |
| March 31, 2024 | $94.44M | -52.6% | -19.5% |
| December 31, 2023 | $117.35M | -47.2% | -15.1% |
- INOVIO PHARMACEUTICALS, INC. showed a decrease of -64.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, INOVIO PHARMACEUTICALS, INC.’s stockholders equity has grown by 26.1% (from $19.11 million to $24.10 million).
- The most recent figure is from INOVIO PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: